Research Protocols
The Pacific Northwest Node has participated in numerous CTN treatment research protocols and ancillary studies since joining the CTN in 2001, in collaboration with community treatment programs and primary care providers in our region and the broader CTN. In addition, the Pacific Northwest Node manages the CTN Dissemination Library for the whole NIDA Clinical Trials Network.
Current Protocols
CTN-0122
Comprehensive Meta-Analysis of CTN Treatment Outcomes by Race and Sex
CTN-0107
Peer Recovery Support: A Bridge to Treatment for Overdose Survivors (NIH HEAL Initiative)
Site: Providence Everett
CTN-0102
Rural Expansion of Medication Treatment for Opioid Use Disorder (NIH HEAL Initiative)
Sites: Ferry County Health, Providence Health Care (Colville, WA), St. Mary’s Hospital, and Syringa Hospital
CTN-0099
Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)
Sites: Univ. of Washington Medical Center and Alameda Health Systems, CA
CTN-0099-A-1
Ancillary to ED-INNOVATION study
Site: Alameda Health Systems, CA
CTN-0096 (S. Radin, Co-Investigator)
Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative)
CTN-0091 (L.M. Baldwin, Lead-Investigator)
Preventing and Identifying Opioid Use Disorder Using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management (NIH HEAL Initiative)
CTN-0087 (A. Saxon, Co-Investigator)
A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration (NIH HEAL Initiative)
CTN-0085 (D. Donovan, Co-Investigator)
Selection Bias-Free Estimation of the Impact of Drug-Focused 12-step Mutual Help Groups (NIH HEAL Initiative)
CTN-0082 (Co-Lead Node)
Implementation Survey of PrEP and Opioid Use Related Services In STI Clinics and Community Based Organizations (CBOs)
CTN-0080
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)
Site: Swedish Hospital
CTN-0078-ot
Knowledge of and Attitudes About Medication Assisted Treatment within American Indian Communities
Site: Two Northwest Tribes
CTN-0074
Primary Care Opioid Use Disorders (PROUD) Treatment Trial
Site: Multicare Health System
Completed Protocols
CTN-0069
Opioid Use Disorder in the Emergency Department
Site: Harborview Medical Center
CTN-0051-A1
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study
Site: Evergreen Treatment Services
CTN-0051
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
Site: Evergreen Treatment Services
CTN-0048
Cocaine Use Reduction with Buprenorphine (CURB)
Site: Recovery Centers of King County
CTN-0044
Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
Site: Evergreen Manor
CTN-0040-S (Lead Node)
Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug-Abusing/Dependent Participants
CTN-0034-Ot (Lead Node)
Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives
CTN-0033-Ot-3 (Lead Node)
Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers?
CTN-0031-A-2 (Co-Lead Node)
The Role of Alcohol Consumption Classifications of Alcohol Use Disorders: A Clinical Study
CTN-0031 (Lead Node)
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Sites: Evergreen Manor, Recovery Centers of King County
CTN-0030-A-1
Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
Site: Providence Behavioral Health Services
CTN-0030
Prescription Opioid Addiction Treatment Study (POATS)
Site: Providence Behavioral Health Services
CTN-0027-A-2
Retention of Suboxone Patients in START: Perspectives of Providers and Patients
Site: Evergreen Treatment Services
CTN-0027-A-1
START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
Site: Evergreen Treatment Services
CTN-0027
START (Starting Treatment with Agonist Replacement Therapy) Study
Site: Evergreen Treatment Services
CTN-0019
Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
Site: Evergreen Treatment Services
CTN-0018 (Lead Node)
Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
Site: Evergreen Treatment Services
CTN-0017
HIV and HCV Intervention in Drug Treatment Settings
Site: Recovery Centers of King County
CTN-0015
Women’s Treatment for Trauma and Substance Use Disorders
Site: Residence XII
CTN-0012
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
Sites: Evergreen Treatment Services, Kitsap Recovery Center, Recovery Centers of King County, Triumph Treatment Services
CTN-0008
Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating the Diffusion of Innovation
Sites: All
CTN-0003
Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules
Site: Providence Behavioral Health Services
